Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
6 pending office actions • 4 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready
UNIVERSITAIR ZIEKENHUIS ANTWERPEN has 5 pending office actions in the Biotechnology & Pharmaceuticals technology area. These matters are distributed across 3 distinct art units. The portfolio involves 5 distinct examiners, showing no overlap in examiner assignments for the current pending actions. This distribution suggests that the company is engaging with a wide variety of perspectives at the patent office within the biotechnology sector.
HOLT, ANDRIAE M is the busiest examiner, with 1 pending office action. Since each of the 5 pending office actions is assigned to a different examiner, the prosecution strategy must be tailored to 5 individual perspectives across the 3 distinct art units. This distribution suggests a need for versatile arguments that satisfy the specific requirements of multiple examiners. Practitioners should note that with 5 distinct examiners, there is no single point of contact for the majority of the pending portfolio.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (17%) |
| §103 only | 3 (50%) |
| §112 only | 1 (17%) |
| Multi-statute (no §101) | 1 (17%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HOLT, ANDRIAE M | 1 | 49.3% | +22.9% |
| LIU, CHU CHUAN | 1 | 71.2% | +14.8% |
| WELCH, WILLOW GRACE | 1 | 55.6% | +46.6% |
| HIBBERT, CATHERINE S | 1 | 58.9% | +48.8% |
| TICHY, JENNIFER M.H. | 1 | 64.9% | +34.5% |
| BERHANE, SELAM | 1 | 58.4% | +56.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18850731 | COMPUTER-IMPLEMENTED METHOD AND SYSTEM FOR DETERMINING A DEGREE OF RESPIRATORY AIRFLOW | LIU, CHU CHUAN | — |
| 18039871 | COMBINATION IMMUNOTHERAPY OF IL-15 AND CD40 AGONIST IN CANCER TREATMENT | HIBBERT, CATHERINE S | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18223218 | BURST STIMULATION PATTERN FOR NEUROMODULATION | WELCH, WILLOW GRACE | 66d overdue |
| 18870744 | Methods of Treating an Eye Disorder | HOLT, ANDRIAE M | — |
| 18850731 | COMPUTER-IMPLEMENTED METHOD AND SYSTEM FOR DETERMINING A DEGREE OF RESPIRATORY AIRFLOW | LIU, CHU CHUAN | — |
| 18039871 | COMBINATION IMMUNOTHERAPY OF IL-15 AND CD40 AGONIST IN CANCER TREATMENT | HIBBERT, CATHERINE S | — |
| 17757356 | OPHTHALMOLOGICAL DEVICE FOR THE TREATMENT OF LSCD AND SUBSTRATE FOR USE IN SAME | TICHY, JENNIFER M.H. | — |
| 17781583 | COMBINATION IMMUNOTHERAPY OF IL-15 AND CD40 AGONIST IN CANCER TREATMENT | BERHANE, SELAM | — |
| Art Unit | Apps |
|---|---|
| 3792 | 1 |
| 1658 | 1 |
| 1653 | 1 |
| 1675 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18870744 | Methods of Treating an Eye Disorder | HOLT, ANDRIAE M | — | §103 | Non-Final OA | — | Pending | Dec 02, 2024 |
| 18850731 | COMPUTER-IMPLEMENTED METHOD AND SYSTEM FOR DETERMINING A DEGREE OF RESPIRATORY AIRFLOW | LIU, CHU CHUAN | — | §101 | Non-Final OA | — | Pending | Sep 25, 2024 |
| 18223218 | BURST STIMULATION PATTERN FOR NEUROMODULATION | WELCH, WILLOW GRACE | 3792 | §103 | Non-Final OA | 66d overdue | Pending | Jul 18, 2023 |
| 18039871 | COMBINATION IMMUNOTHERAPY OF IL-15 AND CD40 AGONIST IN CANCER TREATMENT | HIBBERT, CATHERINE S | 1658 | §102§103§112 | Non-Final OA | — | Pending | Jun 01, 2023 |
| 17757356 | OPHTHALMOLOGICAL DEVICE FOR THE TREATMENT OF LSCD AND SUBSTRATE FOR USE IN SAME | TICHY, JENNIFER M.H. | 1653 | §103 | Final Rejection | — | Pending | Jun 14, 2022 |
| 17781583 | COMBINATION IMMUNOTHERAPY OF IL-15 AND CD40 AGONIST IN CANCER TREATMENT | BERHANE, SELAM | 1675 | §112 | Non-Final OA | — | Pending | Jun 01, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial